title: Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.
abstract: Fifty-six globes that had to be enucleated following ruthenium plaque therapy were examined histopathologically. These eyes account for 10% of all uveal melanomas treated at the University Eye Clinic Essen up until 1985. All but one revealed at least some supposedly viable tumor cells. The most prominent findings within the tumors were tumor cell necrosis, vacuolization and balloon cell degeneration, vascular obstruction and fibrosis of the tumor stroma with accumulation of pigmented macrophages. Tumor necrosis was complete or nearly complete in five cases. Tumor regression correlated with cell type and pigmentary characteristics of the tumor, with epithelioid and heavily pigmented tumor cells being more radiosensitive. Tumor regression was inhomogeneous, possibly due to polyclonality, with tumor cells of varying radiosensitivity, or due to patchy areas of vascular obliteration. Among other ocular structures, extensive subretinal gliosis, chorioretinal atrophy and scarring of the sclera within the field of radiation were observed. Scleral necrosis was present in only five cases and was limited to areas in which the tumor had infiltrated the deep scleral layers. The findings described were considered to reflect radiation injury rather than spontaneous tumor regression when compared to 70 control eyes that had been enucleated without prior treatment for uveal melanoma.
authors.affiliation: Universitäts-Augenklinik, Essen, Federal Republic of Germany.
authors.forename: E
authors.initials: E
authors.lastname: Messmer
authors.forename: N
authors.initials: N
authors.lastname: Bornfeld
authors.forename: M
authors.initials: M
authors.lastname: Foerster
authors.forename: H
authors.initials: H
authors.lastname: Schilling
authors.forename: A
authors.initials: A
authors.lastname: Wessing
mesh_terms: D000368:Aged; D001918:Brachytherapy; D015353:Eye Enucleation; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology* / Q000532:radiotherapy*; D008875:Middle Aged; D011832:Radiation Injuries / Q000473:pathology; D012429:Ruthenium Radioisotopes / Q000627:therapeutic use*; D014604:Uveal Neoplasms / Q000473:pathology* / Q000532:radiotherapy*
chemical_list: D012429:Ruthenium Radioisotopes